about
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic populationEarly metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significanceCoronary atherosclerosis and alcohol consumption: angiographic and mortality data.Coronary artery disease and arterial hypertension: clinical, angiographic and follow-up data.Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss.Effects of glucose tolerance on the changes provoked by glucose ingestion in microvascular function.HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease.Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts.Hypertension, insulin resistance, and the metabolic syndrome.beta-cell function in obesity: effects of weight loss.Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes.Abnormal Glucose Tolerance Is Associated with a Reduced Myocardial Metabolic Flexibility in Patients with Dilated CardiomyopathyA novel fasting blood test for insulin resistance and prediabetes.Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study.Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).Metabolic syndrome: at the crossroads of cardiorenal risk.Measurement of insulin-mediated glucose uptake: direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp.Essential hypertension, metabolic disorders, and insulin resistance.Insulin resistance, adipose depots and gut: interactions and pathological implications.The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives.Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data.The impact of triglycerides on glucose tolerance: Lipotoxicity revisited.Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects.Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies.Glucose uptake saturation explains glucose kinetics profiles measured by different tests.Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.Clinical Phenotype and Microvascular Dynamics of Subjects with Endothelial Dysfunction as Assessed by Peripheral Tonometry.Insulin resistance and hypertension: connections with sodium metabolism.Beta-cell function is associated with carotid intima-media thickness independently of insulin resistance in healthy individuals.Manipulating the sequence of food ingestion improves glycemic control in type 2 diabetic patients under free-living conditions.Impaired insulin action on skeletal muscle metabolism in essential hypertension.Elevated heart rate predicts β cell function in non-diabetic individuals: the RISC cohort.Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial.Syphilis iridocyclitis in a patient with type 1 diabetes.Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo study in patients with neutral lipid storage disease with myopathy.Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E β-cells.In vivo effect of insulin on intracellular calcium concentrations: relation to insulin resistance.Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance.
P50
Q21136353-EF0E85C8-8A97-423A-9368-DB9441D71850Q28279396-E0EE721F-2FB4-44DB-BB73-4D0C0C266ED0Q31037301-F7191E05-9DB0-4834-B98F-E2722B6DF6B0Q31537492-D6D95C54-0BEF-4E41-AFCD-C0A5CE173627Q31829643-C6C4850C-5C95-4BF1-9579-D6CBBEC2ED10Q33326108-4FACCDFC-EEE4-479B-B4B8-2E471613E677Q33680333-A557AD10-6A4A-4BC9-BBDF-FAD67F3F7196Q34940230-A964D7CE-1E69-47E6-9F1C-334813D75DBDQ35781496-3A58B8E8-112B-49D0-97A8-378682BBFF42Q35961983-972740BB-8066-4C15-BC8F-97402674060DQ36123417-516EE718-1D6B-4883-A8EE-1B7166B4D56BQ36424416-0B86AE2B-47ED-4C32-92D4-58CE4A69E590Q36954280-137D1A5E-4870-4EA8-9444-44686BB01345Q37331224-085BB0DA-AFD6-4F71-9233-15507905353EQ37371843-AC61CF36-54C6-4442-B89F-E003DEBBC21AQ37396942-1246A934-5C21-437C-B87E-0FB3187A391CQ37586176-66A7A174-8F0B-4CAB-AB02-7CFFE4D9A069Q37678376-E5B3F9E7-2B18-4AA0-B778-9E9FA2148566Q37701066-734794B9-1F60-41B5-94EF-94B32629D08DQ38463027-0E53CA9F-D136-4C08-9AFE-FFA7DA9C7364Q38678437-518FED0B-2F22-43C1-8922-BBAD65BD041AQ38685625-32DEEFAB-746B-4F9B-A509-46919F459E21Q38912695-BCCB3331-0B73-4384-A5F5-7AA1F670829BQ39094387-8D5B9536-2275-4394-8EEA-68E77FBCFABCQ39721911-35F2110D-F4C9-448B-8147-EDCA0C49E7D1Q39874247-E93B892E-A609-4A1E-A032-717FBE5F5586Q40206988-3279E94D-5D24-47F9-B544-EAE3A20CAA1EQ40341052-CF262795-D7B2-40DE-BCB4-24200EF4E514Q40346593-52C8B2FF-EB01-4982-8699-FBC72C5EBA64Q40907831-3BD50069-10A9-4239-9ABB-96275D78D0F9Q40939812-7E286388-A0D6-4A35-A67A-5A7E9404DC4CQ41085108-F6648C52-B04A-4AEF-AD6E-23E95AEA6A10Q41177765-C29A49F7-1D01-4730-9ABD-297032F8009FQ41701263-BF6FE037-6090-435A-BA02-40B930418724Q42376648-52728A65-40DF-4E8D-856C-EDDA1DC7D02AQ42434504-8A6C1796-A2AF-49AA-A77F-C719137EAD79Q42440877-DD0AFB7C-9F25-4721-A8DE-5CFB9ED1A711Q42502010-1DD36803-6CBF-47CD-90BB-A678AE314759Q42527358-95CD2A04-CBB1-4217-A478-D89BFB1A1D59Q42957586-2CA00513-FE62-466B-8565-1EADD36BFA94
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrea Natali
@ast
Andrea Natali
@en
Andrea Natali
@es
Andrea Natali
@nl
Andrea Natali
@sl
type
label
Andrea Natali
@ast
Andrea Natali
@en
Andrea Natali
@es
Andrea Natali
@nl
Andrea Natali
@sl
prefLabel
Andrea Natali
@ast
Andrea Natali
@en
Andrea Natali
@es
Andrea Natali
@nl
Andrea Natali
@sl
P1053
N-5535-2015
P106
P1153
7007127372
P31
P3829
P496
0000-0002-8465-7717
P569
2000-01-01T00:00:00Z